AcquisitionOther
XOMA Royalty Corporation acquired Turnstone Biologics Corp.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
XOMA Royalty Corporation -> Turnstone Biologics Corp. · $0.34 per share plus CVR
Acquire biotech company with selected tumor-infiltrating lymphocyte therapy platform.
Open source record (SEC) ↗